Alsuma Approval History 
- FDA approved: Yes (First approved June 29th, 2010)
- Brand name: Alsuma
- Generic name: sumatriptan
- Company: King Pharmaceuticals, Inc. (now part of Pfizer - October 2010)
- Treatment for: Migraine, Cluster Headaches
Alsuma (sumatriptan injection) is a triptan indicated for the acute treatment of migraine attacks and cluster headache episodes.
FDA Approval History for Alsuma
| Date | Article |
|---|---|
| Jul 7, 2010 |  FDA Approves Alsuma Auto-Injector |
See also...
Alsuma (sumatriptan) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
